GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » Institutional Ownership

JCR Pharmaceuticals Co (TSE:4552) Institutional Ownership : 11.05% (As of Jun. 06, 2024)


View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, JCR Pharmaceuticals Co's institutional ownership is 11.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, JCR Pharmaceuticals Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, JCR Pharmaceuticals Co's Float Percentage Of Total Shares Outstanding is 0.00%.


JCR Pharmaceuticals Co Institutional Ownership Historical Data

The historical data trend for JCR Pharmaceuticals Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCR Pharmaceuticals Co Institutional Ownership Chart

JCR Pharmaceuticals Co Historical Data

The historical data trend for JCR Pharmaceuticals Co can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 13.76 14.14 14.07 13.96 13.63 13.55 11.56 10.88 11.04 11.05

JCR Pharmaceuticals Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


JCR Pharmaceuticals Co (TSE:4552) Business Description

Traded in Other Exchanges
Address
3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.

JCR Pharmaceuticals Co (TSE:4552) Headlines

No Headlines